167 results on '"Nejman-Gryz, Patrycja"'
Search Results
2. The expression of IL17RA on sputum macrophages in asthma patients
3. Epithelial-macrophage-dendritic cell interactions impact alarmins expression in asthma and COPD
4. Interactions of nasal epithelium with macrophages and dendritic cells variously alter urban PM-induced inflammation in healthy, asthma and COPD
5. Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD
6. Comparison of Thymic Stromal Lymphopoietin Concentration in Various Human Biospecimens from Asthma and COPD Patients Measured with Two Different ELISA Kits
7. Review of: "Sputum Interleukin-32 in childhood asthma: correlation with IL-1β"
8. Erratum to Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD
9. Serum Amyloid A in Stable Patients with Chronic Obstructive Pulmonary Disease Does Not Reflect the Clinical Course of the Disease
10. The Role of Chitinases in Chronic Airway Inflammation Associated with Tobacco Smoke Exposure
11. The effect of 1,25-dihydroxyvitamin D3 on TSLP, IL-33 and IL-25 expression in respiratory epithelium
12. Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
13. Blood and Sputum Eosinophils of COPD Patients Are Differently Polarized than in Asthma.
14. Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients
15. Erratum to Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD
16. Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
17. Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD
18. Comparison of Thymic Stromal Lymphopoietin Concentration in Various Human Biospecimens from Asthma and COPD Patients Measured with Two Different ELISA Kits
19. Inflammatory Phenotypes of Cough Variant Asthma as Response Predictors to Anti-Asthmatic Therapy
20. Blood eosinophils as a predictor of treatment response in adults with difficult-to-treat chronic cough
21. The expression of IL17RA (the common subunit of IL-17A and IL-25 receptor) on sputum macrophages in asthma patients
22. Phenotypic Variations of Mild-to-Moderate Obstructive Pulmonary Diseases According to Airway Inflammation and Clinical Features
23. Periostin and Thymic Stromal Lymphopoietin—Potential Crosstalk in Obstructive Airway Diseases
24. Periostin and TSLP-a potential crosstalk in obstructive airway diseases
25. The Expressions of TSLP, IL-33, and IL-17A in Monocyte Derived Dendritic Cells from Asthma and COPD Patients are Related to Epithelial–Macrophage Interactions
26. Exhaled Biomarkers in Idiopathic Pulmonary Fibrosis—A Six-Month Follow-up Study in Patients Treated with Pirfenidone
27. Is the composition of exhaled breath condensate a key to explain the course of COVID-19 in children?
28. Is the composition of exhaled breath condensate a key to explain the course of COVID-19 in children?
29. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
30. EBC periostin concentration in children with mild-to moderate asthma
31. Expression of CCR3 on sputum macrophages in asthma, COPD and healthy subjects
32. Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
33. Periostin concentration in exhaled breath condensate in children with mild asthma
34. mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis
35. Periostin concentration in exhaled breath condensate in children with mild asthma.
36. Expression of TSLP and IL-33 receptors on sputum macrophages of asthma patients and healthy subjects
37. Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis?
38. CHIT1 is a novel therapeutic target in idiopathic pulmonary fibrosis (IPF): anti-fibrotic efficacy of OATD-01, a potent and selective chitinase inhibitor in the mouse model of pulmonary fibrosis
39. Sputum cytokine profiling according to the type of airway inflammation in obstructive pulmonary diseases
40. The expression of selected biomarkers at the systemic and local level in patients with COPD
41. Inflammatory biomarkers in the evaluation of two-year outcomes of omalizumab treatment in severe allergic asthma.
42. Serum amyloid A in patients with stable chronic obstructive pulmonary disease
43. Genetic characterization of macrophages from induced sputum of asthma and COPD patients
44. Exhaled matrix metalloproteinase 9 in patients with stable COPD - an observational study
45. Comparative Study of IL-33 and IL-6 Levels in Different Respiratory Samples in Mild-to-Moderate Asthma and COPD
46. Sputum interleukin-25 correlates with asthma severity: a preliminary study
47. Menopausal asthma–much ado about nothing? An observational study
48. The association between serological features of chronicChlamydia pneumoniaeinfection and markers of systemic inflammation and nutrition in COPD patients
49. The association between Chlamydia pneumoniae chronic infection and inflammation in COPD patients
50. Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.